Kiniksa Pharmaceuticals
KNSA
KNSA
222 hedge funds and large institutions have $1.77B invested in Kiniksa Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 78 increasing their positions, 71 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
9% more funds holding
Funds holding: 203 → 222 (+19)
10% more repeat investments, than reductions
Existing positions increased: 78 | Existing positions reduced: 71
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Holders
222
Holding in Top 10
4
Calls
$64.6M
Puts
$2.79M
Top Buyers
| 1 | +$280M | |
| 2 | +$33.8M | |
| 3 | +$20.5M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$17.5M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$17.2M |
Top Sellers
| 1 | -$26.9M | |
| 2 | -$18.2M | |
| 3 | -$13.2M | |
| 4 |
Walleye Capital
New York
|
-$10.8M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$10.7M |
